Cancer heterogeneity in vivo and ex vivo- challenges for immunotherapy

Speaker: prof. dr hab. Natalia Marek-Trzonkowska, International Centre for Cancer Vaccine Science (ICCVS), University of Gdańsk

Talk:  Cancer heterogeneity in vivo and ex vivo- challenges for immunotherapy

Time: 06.06.2025, 9:00 am

Venue: Intercollegiate Faculty of Biotechnology, Abrahama 58, hall 042B

Prof. dr hab. Natalia Marek-Trzonkowska is the director of the International Centre for Cancer Vaccine Science (ICCVS) at the University of Gdańsk. Her research focuses on the clinical application of immune cells. She is the author of numerous publications and patents, including the first application of regulatory T cells (Tregs) in the treatment of type 1 diabetes in children. Currently, she has been working on cellular therapy for non-small cell lung cancer. She is a recipient of the Kościuszko Foundation's award, the Scholarship of the Minister of Science and Higher Education for Outstanding Young Scientists, and the Award of the Minister of Education and Science for Significant Achievements in Implementation Activities. The research conducted by prof. Marek- Trzonkowska has also been recognized with national and international societies, including the Polish-American Medical Society, the Polish Academy of Sciences, the International Society of Pediatric and Adolescent Diabetes (ISPAD), the European Federation of Immunological Societies (EFIS), and the International Islet and Pancreas Transplantation Association (ISPAD).

Prof. Marek- Trzonkowska will provide a lecture entitled “Cancer heterogeneity in vivo and ex vivo- challenges for immunotherapy”. During this talk she will discuss importance of understanding the diversity of populations comprising the cancer microenvironment, as well as the impact of preclinical models on cancer immunogenicity.